[go: up one dir, main page]

EE9800451A - Novel imidazotriazolopyrimidines, their preparation and their use as therapeutic substances - Google Patents

Novel imidazotriazolopyrimidines, their preparation and their use as therapeutic substances

Info

Publication number
EE9800451A
EE9800451A EE9800451A EE9800451A EE9800451A EE 9800451 A EE9800451 A EE 9800451A EE 9800451 A EE9800451 A EE 9800451A EE 9800451 A EE9800451 A EE 9800451A EE 9800451 A EE9800451 A EE 9800451A
Authority
EE
Estonia
Prior art keywords
imidazotriazolopyrimidines
novel
preparation
therapeutic substances
therapeutic
Prior art date
Application number
EE9800451A
Other languages
Estonian (et)
Inventor
K�fner-M�hl Ulrike
Kummer Werner
Pohl Gerald
Gaida Wolfram
Lehr Erich
Mierau Joachim
Weiser Thomas
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Priority claimed from CA002242097A external-priority patent/CA2242097C/en
Publication of EE9800451A publication Critical patent/EE9800451A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9800451A 1996-07-20 1997-07-17 Novel imidazotriazolopyrimidines, their preparation and their use as therapeutic substances EE9800451A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19629378A DE19629378A1 (en) 1996-07-20 1996-07-20 New triazolopurines, process for their preparation and their use as medicaments
PCT/EP1997/003841 WO1998003511A1 (en) 1996-07-20 1997-07-17 New triazolopurines, method of preparing them and their use as drugs
CA002242097A CA2242097C (en) 1996-07-20 1998-06-26 Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions

Publications (1)

Publication Number Publication Date
EE9800451A true EE9800451A (en) 1999-06-15

Family

ID=32963000

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800451A EE9800451A (en) 1996-07-20 1997-07-17 Novel imidazotriazolopyrimidines, their preparation and their use as therapeutic substances

Country Status (25)

Country Link
EP (2) EP0880524B1 (en)
JP (1) JP3020281B2 (en)
CN (1) CN1219936A (en)
AT (1) ATE191913T1 (en)
AU (1) AU3695597A (en)
BG (1) BG102707A (en)
BR (1) BR9710747A (en)
CA (1) CA2256736A1 (en)
CZ (1) CZ265498A3 (en)
DE (2) DE19629378A1 (en)
DK (1) DK0880524T3 (en)
EE (1) EE9800451A (en)
ES (1) ES2147453T3 (en)
GR (1) GR3033842T3 (en)
HR (1) HRP970395A2 (en)
HU (1) HUP9902311A3 (en)
ID (1) ID19106A (en)
IL (1) IL126453A0 (en)
NO (1) NO983860L (en)
PL (1) PL328824A1 (en)
PT (1) PT880524E (en)
SK (1) SK114498A3 (en)
TR (1) TR199801659T2 (en)
WO (1) WO1998003511A1 (en)
ZA (1) ZA976331B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826843A1 (en) * 1998-06-16 1999-12-23 Boehringer Ingelheim Pharma Novel imidazotriazolopyrimidines, process for their preparation and their use as medicaments
US6492377B1 (en) 1998-06-25 2002-12-10 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines with adenosine-antagonistic activity
WO2000012511A1 (en) * 1998-08-27 2000-03-09 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines
US7329668B2 (en) 2003-02-25 2008-02-12 Bristol-Myers Squibb Company Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
US7071333B2 (en) 2003-07-30 2006-07-04 Bristol-Myers Squibb Company Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
BRPI0713619A2 (en) 2006-06-23 2013-01-15 Incyte Corp compound or prodrug or pharmaceutically acceptable salt thereof, composition, and use of the compound.
MX2020008949A (en) 2018-02-27 2021-01-08 Incyte Corp Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors.
JP7391046B2 (en) 2018-05-18 2023-12-04 インサイト・コーポレイション Fused pyrimidine derivatives as A2A/A2B inhibitors
IL279829B2 (en) 2018-07-05 2025-05-01 Incyte Holdings Corp Fused pyrazine derivatives as a2a / a2b inhibitors
JOP20210116A1 (en) 2018-11-30 2023-01-30 Merck Sharp & Dohme 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
TWI829857B (en) 2019-01-29 2024-01-21 美商英塞特公司 Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors
CN112778311B (en) * 2019-11-01 2024-06-04 上海翰森生物医药科技有限公司 Nitrogen-containing cyclic derivative inhibitor, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA902282B (en) * 1989-03-29 1990-12-28 Merrell Dow Pharma Selective adenosine receptor compounds
IT1264901B1 (en) * 1993-06-29 1996-10-17 Schering Plough S P A HETEROCYCLIC ANALOGUES OF 1,2,4-TRIAZOLE(15-C)PYRIMIDINES WITH ANTAGONIST ACTIVITY FOR THE ADENOSINE A2 RECEPTOR
JPH083169A (en) * 1994-06-15 1996-01-09 Yamasa Shoyu Co Ltd 4-Methyl-1H- [1,2,4] triazolo [1,5-a] purin-9 (4H) -ones

Also Published As

Publication number Publication date
EP0978517A3 (en) 2003-11-12
JP2000501420A (en) 2000-02-08
ZA976331B (en) 1999-01-25
DK0880524T3 (en) 2000-07-17
EP0880524A1 (en) 1998-12-02
ID19106A (en) 1998-06-18
SK114498A3 (en) 1999-02-11
BG102707A (en) 1999-09-30
IL126453A0 (en) 1999-08-17
CZ265498A3 (en) 1998-12-16
DE59701467D1 (en) 2000-05-25
DE19629378A1 (en) 1998-01-29
GR3033842T3 (en) 2000-10-31
CN1219936A (en) 1999-06-16
PT880524E (en) 2000-07-31
NO983860L (en) 1998-10-21
EP0880524B1 (en) 2000-04-19
NO983860D0 (en) 1998-08-21
ES2147453T3 (en) 2000-09-01
PL328824A1 (en) 1999-02-15
ATE191913T1 (en) 2000-05-15
BR9710747A (en) 1999-08-17
HUP9902311A3 (en) 2000-06-28
TR199801659T2 (en) 1998-12-21
CA2256736A1 (en) 1998-01-29
HRP970395A2 (en) 1998-08-31
AU3695597A (en) 1998-02-10
EP0978517A2 (en) 2000-02-09
JP3020281B2 (en) 2000-03-15
HUP9902311A2 (en) 1999-10-28
WO1998003511A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
EE9900147A (en) Oxadiazoles, methods for their preparation and use as pharmaceuticals
FI964311L (en) Bifunctional protein, preparation and use
FI955235L (en) Oxazolidinion derivatives, their preparation and use
EE9700145A (en) Cycloalkanepyridines, their method of preparation, their use in the manufacture of medicinal products and medicinal products containing these compounds
EE9900359A (en) Disubstituted bicyclic heterocycles, their preparation and use as pharmaceuticals
PT911340E (en) SUBSTITUTED ISOKINOLINES-3-CARBOXAMIDES, ITS PREPARATION AND USE AS DRUGS
EE9800459A (en) Spiro-piperidine derivatives and their use as therapeutic agents
EE200000037A (en) Acylpiperazinylpyrimidines Derivatives, Their Preparation and Use as Medicaments
EE200200160A (en) 2'-Substituted 1,1'-biphenyl-2-carboxamides, their use and pharmaceutical preparations
FI954763A7 (en) Auxin derivatives, their preparation and their therapeutic use
FI951817A7 (en) Organoaluminate product, its preparation and use
FI956298A0 (en) 3-Phenyl-isoquinolin-1 (2H) -ones, their preparation and therapeutic use
EE9900034A (en) Arylcycloalkanecarboxylic esters, their use, pharmaceutical compositions and their preparation
FI970997L (en) Benzocycloalkene compounds, their preparation and use
EE9800451A (en) Novel imidazotriazolopyrimidines, their preparation and their use as therapeutic substances
FI941068A7 (en) Benzoxazine derivatives, their preparation and therapeutic use
FI940425A7 (en) Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
FI930716A7 (en) New arylcarbonylaminoalkyldihydrooxopyridines, their preparation and use
EE9800333A (en) Novel furanarylmethylidene derivatives, methods for their preparation and use in therapy
EE200000207A (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, their preparation and therapeutic use
FI970750L (en) Indole-2,3-dione-3-oxime derivatives, their preparation and use
EE200000018A (en) 6-Pyrrolidin-2-ylpyridines, their Preparation and Therapeutic Use
FI972965L (en) New peptides, their preparation and use
FI971317A7 (en) Novel heterocyclic, substituted imidazoloquinoxalinones, their preparation and use
FI954141L (en) Oxazoloquinolone derivatives, their preparation and their use in therapy